Skip to main content
. 2025 Mar 5;26(5):2325. doi: 10.3390/ijms26052325
Amyloid-beta
AD Alzheimer’s disease
ADD AD type dementia
ADAS Alzheimer’s dementia assessment scale
aMCI Amnestic mild cognitive impairment
AUC Area under curve
BMI Body mass index
DM Diabetes mellitus
GFAP Glial fibrillary acidic protein
HL Hyperlipidemia
HT Hypertension
LDL Low-density lipoprotein
MMSE Mini-mental state examination
MRI Magnetic resonance imaging
NfL Neurofilament light chain
PET Positron emission tomography
p-tau Phosphorylated tau
ROC Receiver operating characteristic
SCI Subjective cognitive impairment
CSF Cerebrospinal fluid